Medtech Talk

What Went into Fractyl’s $44 million Round? CEO and co-founder Harith Rajagopalan, MD, PhD, discusses his approach to raising new capital and to building the right board.

Anders Wold, president and CEO of GE’s Clinical Care Solutions, is still fascinated by the power new technology can deliver to healthcare. So he’s understandably excited about the opportunities facing this division of GE – and the entire company as well – as we move into healthcare of the future.

The power of Artificial Intelligence and Machine Learning looms over Medtech as a growing force that will bring change, good or bad. In this MedtechTalk Podcast, Michael D. Abramoff, MD, PhD, president and co-founder of IDx, tells how the start-up is using AI to better diagnose diabetic retinopathy. The company hopes to secure FDA approval for its IDx-DR system following the completion of clinical trials this summer.

Medtech and Digital Health technology increasingly have more and more in common. In this Medtech Talk Podcast, Robert Mittendorff, MD, a partner at Norwest Venture Partners, explains how Digital Health companies are facing many of the same challenges that vex Medtech start-ups, including the need to obtain approval under new FDA guidelines and to secure reimbursement payments from insurers

Steve Goedeke says he was the kid who liked to take things apart. But he’s built a career putting things together including a promising neuromodulation start-up called Cardionomic. In this episode, Goedeke shares the thoughts – and concerns – that went into leaving a seemingly stable gig at Medtronic to lead the new company. He also reveals what ideas he’d consider pursuing before a serendipitous ski trip set him on his current path.

John Pavlidis, president and CEO of VytronUS, has built a strong resume leading and selling Medtech start-ups. Now the self-described engineering “nerd” is leading VytronUS, a start-up combining the powers of imaging, ablation, and robotics to create a powerful new tool that can elevate the precision of treating atrial fibrillation in the electrophysiology lab.

Medtech-device design firm Worrell now is envisioning how Virtual Reality, Augmented Reality, and Voice-enabled Technologies like Amazon’s Alexa might treat chronic disease, manage clinical trials, and restore bonds between patients and physicians. We talk with CEO Kai Worrell and Kristen Shardlow, the company’s director of user experience, about the firm’s work in understanding these exciting technologies.

Faced with an unacceptable diagnosis after her husband was seriously injured in an accident, Savonix CEO Mylea Charvat created a tool to measure cognitive function to aid his recovery. Now Savonix seeks to establish cognitive function as a standard measure of human health. The technology potentially could could fill a huge shortage of physicians while improving patient outcomes and accelerating medical innovation.

Nuvaira CEO Dennis Wahr, MD, sees similarities between interventional pulmonology today and interventional cardiology in its early days. He hopes Nuvaira, which is developing a tool to ablate lung tissue, will be able to further the field through upcoming clinical trials and fund-raising.

An ailing wife and son forced Bryan Mazlish to hack a cell phone, glucose monitor, and insulin pump to create an artificial pancreas. In this MedtechTalk Podcast, Jeffrey Brewer, CEO and president of Bigfoot Biomedical, explains how he and Mazlish came to form the privately held start-up. Brewer explains how his son’s diagnosis – and at least one near-fatal experience – pushes him forward to ensure Bigfoot leads the class of next-generation devices that may someday come close to creating a cure for this dreaded disease.Learn More about Medtech Talk: https://goo.gl/o6Ue5u